Novel study evaluates systemic mastocytosis’ effect on patients, providers
Blueprint Medicines released results from the largest-ever European study evaluating the effect of systemic mastocytosis on patients’ lives.
Blueprint Medicines released results from the largest-ever European study evaluating the effect of systemic mastocytosis on patients’ lives.
According to data available, pregnancy can potentially worsen systemic mastocytosis, and the growth and delivery of the baby may be affected.
The successful management of SM flare-ups can significantly improve your health and overall quality of life.
Histamine intolerance is common in people with SM, but avoiding triggers and adopting a healthy lifestyle can help.
While systemic mastocytosis (SM) is considered a genetic disorder, it is not a condition that is typically inherited.